Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chemotherapy and radiation therapy with or without Efaproxiral for stage III non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Efaproxiral (efaproxiral)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Lung Cancer | Phase 3 | Status: WITHDRAWN